Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Phenylalanine 4 hydroxylase or Phenylalanine hydroxylase (PAH) is an enzyme that catalyzes the hydroxylation of the aromatic side-chain of phenylalanine to generate tyrosine. Tyrosine is used to make several types of hormones, certain chemicals that transmit signals in the brain (neurotransmitters), and a pigment called melanin, which gives hair and skin their color. The Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) Development market research report provides an in-depth analysis of Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) targeted pipeline therapeutics.
The report provides comprehensive information on the Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) targeted therapeutics development with respective active and dormant or discontinued projects.
Mechanisms of Action of Phenylalanine 4 Hydroxylase Pipeline Market
The mechanisms of action of the Phenylalanine 4 Hydroxylase pipeline market are Phenylalanine 4 Hydroxylase Activator and Phenylalanine 4 Hydroxylase Replacement.
Phenylalanine 4 Hydroxylase pipeline market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in Phenylalanine 4 Hydroxylase Pipeline Market
The routes of administration in the Phenylalanine 4 Hydroxylase pipeline market are intravenous and oral.
Phenylalanine 4 Hydroxylase pipeline market, by routes of administration
For more routes of administration insights, download a free report sample
Molecule Types in Phenylalanine 4 Hydroxylase Pipeline Market
The molecule types in the Phenylalanine 4 Hydroxylase pipeline market are gene therapy, oligonucleotide, small molecule, gene-modified cell therapy, and recombinant enzyme.
Phenylalanine 4 Hydroxylase pipeline market, by molecule types
For more molecule type insights, download a free report sample
Key Phenylalanine 4 Hydroxylase Pipeline Market Companies
Some of the key companies in the Phenylalanine 4 Hydroxylase pipeline market are Agios Pharmaceuticals Inc, American Gene Technologies International Inc, Castle Creek Biosciences Inc, CommBio Therapeutics Co Ltd, Evox Therapeutics Ltd, Homology Medicines Inc, iECURE, Moderna Inc, Nestle Health Science, and Pluvia AS.
Phenylalanine 4 Hydroxylase pipeline market, by companies
To know more about key companies, download a free report sample
Market report overview
Mechanisms of Action |
Phenylalanine 4 Hydroxylase Activator and Phenylalanine 4 Hydroxylase Replacement |
Routes of Administration | Intravenous and Oral |
Molecule Types | Gene Therapy, Oligonucleotide, Small Molecule, Gene-Modified Cell Therapy, and Recombinant Enzyme |
Key Companies | Agios Pharmaceuticals Inc, American Gene Technologies International Inc, Castle Creek Biosciences Inc, CommBio Therapeutics Co Ltd, Evox Therapeutics Ltd, Homology Medicines Inc, iECURE, Moderna Inc, Nestle Health Science, and Pluvia AS |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1).
- Reviews of Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) therapeutics and enlists all their major and minor projects.
- Assessment of Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1).
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1).
- Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
American Gene Technologies International Inc
Castle Creek Biosciences Inc
CommBio Therapeutics Co Ltd
Evox Therapeutics Ltd
Homology Medicines Inc
iECURE
Moderna Inc
Nestle Health Science
Pluvia AS
Ultragenyx Pharmaceutical Inc
Vera Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the mechanisms of action of the Phenylalanine 4 Hydroxylase pipeline market?
The mechanisms of action of the Phenylalanine 4 Hydroxylase pipeline market are Phenylalanine 4 Hydroxylase Activator and Phenylalanine 4 Hydroxylase Replacement.
-
What are the routes of administration in the Phenylalanine 4 Hydroxylase pipeline market?
The routes of administration in the Phenylalanine 4 Hydroxylase pipeline market are intravenous and oral.
-
What are the molecule types in the Phenylalanine 4 Hydroxylase pipeline market?
The molecule types in the Phenylalanine 4 Hydroxylase pipeline market are gene therapy, oligonucleotide, small molecule, gene-modified cell therapy, and recombinant enzyme.
-
Which are the key companies in the Phenylalanine 4 Hydroxylase pipeline market?
Some of the key companies in the Phenylalanine 4 Hydroxylase pipeline market are Agios Pharmaceuticals Inc, American Gene Technologies International Inc, Castle Creek Biosciences Inc, CommBio Therapeutics Co Ltd, Evox Therapeutics Ltd, Homology Medicines Inc, iECURE, Moderna Inc, Nestle Health Science, and Pluvia AS.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.